Is this you?
Request access for Louisiana Research Center with your @laresearch.org work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Louisiana Research Center
Unclaimed profileIndependent Site · Shreveport, Louisiana · ~1 sites
Intera lens
ICP 6Lift (cardio sample) 0.13Recruit soph 0.57
Quality Scorecard (1–100)
Overall68Recruit54Ops80Sponsor67Ther69
Performance (observed)
Historical trials
145
Completed
99
Terminated/Withdrawn
10
Completion rate
91%
Active now
32
Phase 2
37
Phase 3
72
Realized enrollment
157,503
First study year
1995
Years active
31
Match confidence
high
Enrollment velocity (inf)
5,081
Therapeutic
Areas
Gastroenterology, Fatty Liver (NASH), Hepatitis, Inflammatory Bowel Disease, Irritable Bowel Syndrome, GERD, Hepatology
Specialties
Gastroenterology (peptic ulcer, GERD, IBD, IBS, NASH, Hepatitis C)
Breadth (conditions)
280
States
Louisiana
Recruitment (web observed)
Trial Finder
Yes
Patient database
Y; large population base
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Established 1992; active recruitment
Capability notes
High - award-winning recruitment & retention
Relationships
Sponsors
SWOG Cancer Research Network; Pfizer; National Cancer Institute (NCI); AbbVie; NSABP Foundation Inc; Eastern Cooperative Oncology Group
CROs
ICON Clinical Research; Medpace, Inc.; MicroConstants; The Emmes Company, LLC
Partnerships
GastroIntestinal Specialists, A.M.C.
Owner / parent
Owned by GastroIntestinal Specialists, A.M.C. (founded 1979); LRC formed from successful studies
Expansion
2 locations
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
unitedstates@bitrialsupport.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Based at 1800 East 70th Street, Shreveport, LA. ClinicalTrials.gov validation: 6 active recruiting cardiometabolic trials (27 active of 115 total). Founded from successful GI studies (1992+); formal LRC launch after achievements. Part of larger GIS group (13 physicians, 16+ mid-level practitioners). Strong GI/hepatology focus. Award-winning patient recruitment.
Recommendation features (sample indication)
Ind fit 0.30Liftability 0.13Overall68
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.